2022
DOI: 10.3389/fbioe.2022.882308
|View full text |Cite
|
Sign up to set email alerts
|

pH/Redox/Lysozyme-Sensitive Hybrid Nanocarriers With Transformable Size for Multistage Drug Delivery

Abstract: The majority of current nanocarriers in cancer treatment fail to deliver encapsulated cargos to their final targets at therapeutic levels, which decreases the ultimate efficacy. In this work, a novel core–shell nanocarrier with a biodegradable property was synthesized for efficient drug release and subcellular organelle delivery. Initially, silver nanoparticles (AgNPs) were grafted with terminal double bonds originating from N, N′-bisacrylamide cystamine (BAC). Then, the outer coatings consisting of chitosan (… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 55 publications
0
2
0
Order By: Relevance
“…After being incubated in PBS (pH 5.0) with GSH (5 mM) and lysozyme (5 μg ml −1 ), the size of the nanoparticles decreased from approximately 175 nm to 10-20 nm. CAB@DOX with this size variable feature facilitates nuclear delivery of DOX [89].…”
Section: Size Variation Of Nanocarriersmentioning
confidence: 99%
“…After being incubated in PBS (pH 5.0) with GSH (5 mM) and lysozyme (5 μg ml −1 ), the size of the nanoparticles decreased from approximately 175 nm to 10-20 nm. CAB@DOX with this size variable feature facilitates nuclear delivery of DOX [89].…”
Section: Size Variation Of Nanocarriersmentioning
confidence: 99%
“…Enzymatic catalytic activity was indicated as another possible trigger for chitosan-coated smart DDS [ 191 ]. The release of doxorubicin was enhanced, incubating chitosan-coated hollow MSNs with colon enzymes [ 141 ].…”
Section: Functionalization Of Msns With Biopolymersmentioning
confidence: 99%